PSIL AdvisorShares Psychedelics ETF

33

NYSE ARCA | ETF

Price
$11.05
Decreased by -4.76%
Dollar volume (20D)
60.63 K
ADR%
2.28
Healthcare - 100.00%Basic Materials - 0.00%Communication Services - 0.00%Consumer Cyclicals - 0.00%Consumer Defensive - 0.00%Energy - 0.00%Financial Services - 0.00%Industrials - 0.00%Real Estate - 0.00%Technology - 0.00%Utilities - 0.00%
Healthcare - 100.00%
Basic Materials - 0.00%
Communication Services - 0.00%
Consumer Cyclicals - 0.00%
Consumer Defensive - 0.00%
Energy - 0.00%
Financial Services - 0.00%
Industrials - 0.00%
Real Estate - 0.00%
Technology - 0.00%
Utilities - 0.00%

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities.

The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business.

The fund is non-diversified.

Top 20 Holdings

Asset Name Sector Industry Weight
MNMD Mind Medicine Inc Healthcare Biotechnology 8.05%
CYBN Cybin Inc Healthcare Biotechnology 7.94%
SAGE Sage Therapeutic Healthcare Biotechnology 7.65%
ALKS Alkermes Plc Healthcare Drug Manufacturers - Specialty & Generic 7.59%
CYBN Cybin Inc Healthcare Biotechnology 7.55%
NRXP NRX Pharmaceuticals Inc Healthcare Biotechnology 6.77%
ATAI ATAI Life Sciences BV Healthcare Biotechnology 6.40%
TTTXX BlackRock Liquidity Funds - Treasury Trust Fund 5.27%
QNTM Quantum BioPharma Ltd Ordinary Shares - Class B (Sub Voting) 5.20%
STIM Neuronetics Inc Healthcare Diagnostics & Research 5.10%
ITCI Intracellular Th Healthcare Drug Manufacturers - Specialty & Generic 4.67%
CMPS Compass Pathways Plc Healthcare Medical Care Facilities 4.63%
NBIX Neurocrine Biosciences Inc Healthcare Drug Manufacturers - Specialty & Generic 4.54%
GHRS GH Research PLC Healthcare Biotechnology 4.22%
SLZA ENVERIC BIOSCI.INC.DL-01 Healthcare Biotechnology 1.97%
SILO Silo Pharma Inc Healthcare Biotechnology 1.67%
RLMD Relmada Therapeutics Inc Healthcare Biotechnology 0.86%
NUMI Numinus Wellness Inc Healthcare Medical Care Facilities 0.72%
GBNH Greenbrook TMS Inc Healthcare Medical Care Facilities 0.26%
PSYB PSYBIO THERAP. (SUB.VT.) 0.00%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY